Nuveen Asset Management, LLC - ADMA BIOLOGICS INC ownership

ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 68 filers reported holding ADMA BIOLOGICS INC in Q2 2019. The put-call ratio across all filers is 1.49 and the average weighting 0.4%.

Quarter-by-quarter ownership
Nuveen Asset Management, LLC ownership history of ADMA BIOLOGICS INC
ValueSharesWeighting
Q3 2023$38,255,644
+21.1%
10,685,934
+24.8%
0.01%
+18.2%
Q2 2023$31,583,215
+105540.1%
8,559,137
-5.2%
0.01%0.0%
Q1 2023$29,897
+2.0%
9,032,313
+19.6%
0.01%0.0%
Q4 2022$29,304
-99.9%
7,552,507
-13.2%
0.01%
+22.2%
Q3 2022$21,150,000
+49.1%
8,703,733
+21.5%
0.01%
+80.0%
Q2 2022$14,181,000
+19.7%
7,162,189
-5.7%
0.01%
+25.0%
Q1 2022$11,848,000
-20.8%
7,594,940
-28.4%
0.00%0.0%
Q4 2021$14,964,000
+92.3%
10,612,600
+54.1%
0.00%
+100.0%
Q3 2021$7,780,000
-17.6%
6,884,640
+16.6%
0.00%
-33.3%
Q2 2021$9,446,000
-20.6%
5,903,659
-12.7%
0.00%
-25.0%
Q1 2021$11,895,000
+2274.3%
6,758,962
+2530.6%
0.00%
Q4 2020$501,000
-18.0%
256,937
+0.6%
0.00%
Q3 2020$611,000
-44.4%
255,530
-31.8%
0.00%
Q2 2020$1,098,000
-49.9%
374,744
-50.7%
0.00%
-100.0%
Q1 2020$2,191,000
+96.5%
760,576
+172.9%
0.00%
Q4 2019$1,115,000
+87.4%
278,700
+108.3%
0.00%
Q3 2019$595,000
+122.0%
133,787
+93.6%
0.00%
Q2 2019$268,00069,0940.00%
Other shareholders
ADMA BIOLOGICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Biomark Capital Management Co. LLC 1,433,304$6,464,00099.88%
Broadfin Capital, LLC 3,249,829$14,657,0002.31%
Stonepine Capital Management, LLC 831,731$3,751,0002.28%
Aisling Capital LLC 3,608,171$16,273,0002.14%
Consonance Capital Management LP 4,249,234$19,164,0001.24%
MORGENS WATERFALL VINTIADIS & CO INC 375,000$1,691,0001.20%
Perceptive Advisors 6,521,102$29,410,0000.77%
PURA VIDA INVESTMENTS, LLC 325,000$1,466,0000.59%
683 Capital Management, LLC 885,000$3,991,0000.27%
ARDSLEY ADVISORY PARTNERS LP 80,000$361,0000.05%
View complete list of ADMA BIOLOGICS INC shareholders